Literature DB >> 6993319

Glucose clamping using the Biostator GCIIS.

C A Verdonk, R A Rizza, R E Westland, R L Nelson, J E Gerich, F J Service.   

Abstract

The Biostator GCIIS was used to clamp circulating glucose at hypoglycemic (42 +/- 1 mg/dl), euglycemic (86 +/- 2 mg/dl), and hyperglycemic (142 +/- 1 mg/dl) levels in normal subjects during a concomitant infusion of insulin (0.1 U/kg/h). Because of limitations in maximal glucose infusion (1 g/min) from the Biostator, a supplementary infusion of glucose was required to accomplish euglycemic and hyperglycemic clamps. The coefficients of variation of blood glucose were 7.06 +/- 1.3%, 5.9 +/- 0.5%, and 6.1 +/- 0.9 for 120 minutes of hypoglycemic, euglycemic, and hyperglycemic clamps, respectively. Despite the occasional interruption of blood flow in the double-lumen catheter and the occasional poor correlation between Biostator and reference glucose method, satisfactory glucose clamps could be maintained for 2 hours.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6993319     DOI: 10.1055/s-2007-996224

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  14 in total

Review 1.  Recent developments in insulin delivery techniques. Current status and future potential.

Authors:  F P Kennedy
Journal:  Drugs       Date:  1991-08       Impact factor: 9.546

Review 2.  Can technological solutions for diabetes replace islet cell function?

Authors:  Justin M Gregory; Daniel J Moore
Journal:  Organogenesis       Date:  2011-01-01       Impact factor: 2.500

3.  How to Assess the Quality of Glucose Clamps? Evaluation of Clamps Performed With ClampArt, a Novel Automated Clamp Device.

Authors:  Carsten Benesch; Tim Heise; Oliver Klein; Lutz Heinemann; Sabine Arnolds
Journal:  J Diabetes Sci Technol       Date:  2015-04-07

4.  Development and testing of a simple algorithm for a glucose clamp.

Authors:  S M Furler; G S Zelenka; E W Kraegen
Journal:  Med Biol Eng Comput       Date:  1986-07       Impact factor: 2.602

5.  Blood collection while using a continuous glucose analyzer without insertion of an additional venous catheter.

Authors:  M J Castillo; A J Scheen; A S Luyckx; P J Lefèbvre
Journal:  Diabetologia       Date:  1983-08       Impact factor: 10.122

6.  A comparison of the artificial pancreas (glucose controlled insulin infusion system) and a manual technique for assessing insulin sensitivity during euglycaemic clamping.

Authors:  M Ponchner; R J Heine; A Pernet; I Hanning; A J Francis; D Cook; H Orskov; K G Alberti
Journal:  Diabetologia       Date:  1984-06       Impact factor: 10.122

7.  Laparoscopic cholecystectomy does not prevent the postoperative protein catabolic response in muscle.

Authors:  P Essén; A Thorell; M A McNurlan; S Anderson; O Ljungqvist; J Wernerman; P J Garlick
Journal:  Ann Surg       Date:  1995-07       Impact factor: 12.969

8.  Comparison of acute and subacute effects of deflazacort and prednisone on glucose metabolism in man.

Authors:  P Cavallo-Perin; A Bruno; A Ozzello; A M Dall'Omo; A Lombardi; M Cassader; B Imbimbo; G Pagano
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

9.  Factors for development of secondary failure to sulfonylurea drugs in non-insulin-dependent diabetes mellitus.

Authors:  A M Borissova; D G Koev; M G Minev; F G Martinova; P I Gencova; G G Kirilov; J Arnaudov
Journal:  Acta Diabetol Lat       Date:  1991 Jan-Mar

10.  Prolonged hyperglycaemia during infusion of glucose and somatostatin impairs pancreatic A- and B-cell responses to decrements in plasma glucose in normal man: evidence for induction of altered sensitivity to glucose.

Authors:  G Dimitriadis; P Cryer; J Gerich
Journal:  Diabetologia       Date:  1985-02       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.